- $8.72bn
- $8.22bn
- $108.78m
U.S. STOCKS ON THE MOVE-Pliant Therapeutics, Skechers USA, Inspira Tech
U.S. STOCKS ON THE MOVE-Pliant Therapeutics , Wayfair, Evoqua Water Technologies
U.S. STOCKS ON THE MOVE-BiondVax Pharma, Evoqua Water, Wayfair
J.P. Morgan raises ImmunoGen's PT on ovarian cancer drug prospects
U.S. RESEARCH ROUNDUP-Apollo Endosurgery, Comerica, State Street Corp
Brief: Immunogen Appoints Michael Vasconcelles, MD, As Executive Vice President, Research, Development, And Medical Affairs
U.S. STOCKS ON THE MOVE-Dynagas, Disc Medicine, Walmart
U.S. STOCKS ON THE MOVE-Silo Pharma, Meta Platforms, Campbell Soup
ImmunoGen drops as H.C. Wainwright cuts PT
U.S. RESEARCH ROUNDUP-Immunogen, LXP Industrial Trust, TG Therapeutics
Brief: ImmunoGen Appoints Renee Lentini As Interim CFO
Brief: Biosion USA Says Announced Research Collaboration To Create Antibody-Drug Conjugates With Immunogen
Brief: Immunogen Presents Findings From Expansion Cohorts In Phase 1B/2 Study Of Pivekimab Sunirine With Vidaza® And Venclexta® In Acute Myeloid Leukemia At Ash
U.S. STOCKS ON THE MOVE-Johnson Outdoors, agilon health, Phreesia
U.S. STOCKS ON THE MOVE-Arcellex, Ambrx Biopharma, Boeing
U.S. STOCKS ON THE MOVE-Gold miners, Boeing, Ambrx Biopharma
Brief: ImmunoGen To Collaborate With Gilead To Evaluate Pivekimab With Magrolimab
ImmunoGen rises on cancer trial collaboration with Gilead
Truist initiates coverage of ImmunoGen with 'buy' rating, shares up